Codexis (CDXS) Gross Margin Growth (3y) (2013 - 2026)

Codexis (CDXS) Gross Margin Growth (3y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 722.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -191.00
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -162.00
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -40.00
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Codexis 135.70 Mn 70.56 Mn 13.18 Mn 2,129.00

Historic Data

Download Data
DateValue
Mar 31, 2026 2,129.00
Dec 31, 2025 3,746.00
Sep 30, 2025 -27.00
Jun 30, 2025 1,566.00
Mar 31, 2025 -1,211.00
Dec 31, 2024 1,075.00
Sep 30, 2024 -1,496.00
Jun 30, 2024 -2,642.00
Mar 31, 2024 -504.00
Dec 31, 2023 -2,938.00
Sep 30, 2023 -443.00
Jun 30, 2023 -5,221.00
Mar 31, 2023 -1,750.00
Dec 31, 2022 -2,447.00
Sep 30, 2022 -526.00
Jun 30, 2022 -684.00
Mar 31, 2022 407.00
Dec 31, 2021 -1,289.00
Sep 30, 2021 370.00
Jun 30, 2021 232.00